Oxcarbazepine Tablet, Film Coated
Product Images NDC 68788-7866

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68788-7866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of Oxcarbazepine showing its bicyclic ring system and indicative functional groups including a ketone and an amide group.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

Kaplan-Meier plot comparing exit rates over time from day 2 to day 11 between oxcarbazepine treatment group and placebo group. The x-axis represents time on trial in days, and the y-axis represents exit rate. Oxcarbazepine is shown with a solid line; placebo is shown with a dotted line. The plot includes a log-rank test p-value of 0.0001 indicating statistical comparison.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve chart depicting seizure rates over days from first dose to first seizure. The graph compares two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days (0 to 140), and the y-axis shows seizure rate (0 to 1). A log-rank test p-value of 0.046 is noted, indicating statistical comparison between the groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier survival curve graph showing exit rate over time to exit in days for two treatment groups labeled HIGH (solid line) and LOW (dotted line). The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve graph depicting exit rate over time in days for two treatment groups labeled HIGH and LOW. The graph includes a log-rank test p-value of 0.0001, showing a clear difference in exit rates between groups across approximately 130 days.*

FDA Label Image

Oxcarbazepine Tablets 600mg (Oxcarbazepine 08)

OXCARBAZEPINE Tablets 600 mg film-coated oral tablets packaging label. The label indicates the product is generic for Trileptal and each tablet contains 600 mg oxcarbazepine USP. Manufactured by Breckenridge Pharmaceuticals, Inc., Boca Raton, FL, and labeled by Preferred Pharmaceuticals Inc. The label includes storage instructions and directions for use in English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.